Fresenius Investigates Akorn FDA Compliance, Says Outcome May Affect Merger


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


What Happened

Akorn, Inc. (NASDAQ:AKRX) shares fell more than 30 percent Monday evening after Fresenius Kabi AG announced an independent investigation into alleged breaches of FDA data integrity requirements related to product development.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Akorn later released a statement confirming its active participation in the probe.

Why It’s Important

The outcome of the investigation may derail a deal between the companies that saw Fresenius buying Akorn for $34 per share. The acquisition was announced in April 2017 and has yet to close.

Akorn assured investors that the transaction should continue as planned.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


“To date, the Company's investigation has not found any facts that would result in a material impact on Akorn's operations and the Company does not believe this investigation should affect the closing of the transaction with Fresenius,” the statement read.

What’s Next

Fresenius noted that it will not provide updates throughout the investigation, but it will continue to seek regulatory clearance for the merger from the Federal Trade Commission.

At time of publication, Akorn shares had marginally recovered and were set to open down 28.7 percent around $21.60.

Related Links:

An Unusual Options Trade Prior To Akorn Takeout Chatter

The Week Ahead In Biotech: Earnings, PDUFA Dates And More


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: NewsFDALegalM&ATop StoriesMoversTrading IdeasFreseniusFresenius Kabi AG